A 12 weeks, randomized, double-blind, placebo-controlled human trial of unripe apple extract on improvement of Hyperglycemia

A 12 weeks, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of unripe apple extract on improvement of Hyperglycemia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0005724

Enrollment

Registered

2020-12-30

Start date

2019-11-19

Completion date

Unknown

Last updated

2021-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : • unripe apple extract group: once a day, 1 tablets once, after breakfast, for 12 weeks(1.5 g/day, 1.5 g/day for unripe apple extract) • Placebo group: once a day, 1 tablets onc

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Males and females aged over 19 years and under 70 years at the screening examination 2) Fasting blood glucose=100 mg/dL and <140 mg/dL 3) Participants who have fully understand the information provided about the study voluntarily decided to participate and agree to comply with precautions

Exclusion criteria

Exclusion criteria: 1) Patients who need care of diabetes at the screening examination. 2) Patients who take medicine for glucose and intake health functional food within 3 months prior to the screening examination. 3) Patients with a history of medicine or alcohol abuse 4) Patients who have participated in other clinical trials within 3 months prior to the screening examination

Design outcomes

Primary

Measure	Time frame
fasting glucose;postprandial glucose	—

Secondary

Measure	Time frame
Insulin;HbA1c(Hemoglobin A1c);lipid profile;C-peptide	—

Countries

Korea, Republic of

Contacts

Public ContactJongcheon Joo

Wonkwang University Oriental Medical Hospital, Jeonju

Outcome results